A new pharmaceutical testing laboratory is planned for space at 8 Glens Falls Tech Park, the site once occupied by Angio.
Who's Behind the New Lab
The lab was co-founded by three people with nearly 40 years of combined pharmaceutical-industry experience, according to The Post-Star.
The lab plans to test pharmaceutical products for other companies as a contract laboratory, serving clients that could include Regeneron itself.
Regeneron Expansion Nearby
Regeneron is expanding at the former Quad Graphics magazine factory in Saratoga Springs. The company announced a $2 billion investment in the project in 2025, the station's report notes. A New York State Department of Environmental Conservation bulletin separately confirmed that the City of Saratoga Springs Planning Board, acting as lead agency, determined the proposed Regeneron project there would not have a significant adverse environmental impact, describing the work as site improvements for an adaptive reuse of the property.
The proposed lab would occupy space at 8 Glens Falls Tech Park, the former Angio site.
Hiring Plans and Safety Oversight
The lab plans to grow to between 20 and 30 employees over the next two to three years, according to the report. Day-to-day operations will involve segregating acids, bases and organic solvents used in pharmaceutical quality-control testing.
The lab will be a regulated facility, with regulatory agencies set to inspect its handling of reagents to ensure compliance. The company also expects to lean on robotic automation as part of its testing processes once operations are underway.
Separately, Regeneron was selected for a new FDA pilot program that could speed approval of its $2 billion Saratoga Springs manufacturing facility, according to the Times Union. Regeneron's planned Saratoga Springs facility is at the former Quad Graphics site.
